Parametric Portfolio Associates’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | $4.48M | Buy |
90,414
+23,397
| +35% | +$1.16M | ﹤0.01% | 1923 |
|
2021
Q4 | $3.41M | Buy |
67,017
+327
| +0.5% | +$16.7K | ﹤0.01% | 2113 |
|
2021
Q3 | $3.72M | Buy |
66,690
+17,545
| +36% | +$979K | ﹤0.01% | 2047 |
|
2021
Q2 | $2.1M | Buy |
49,145
+9,347
| +23% | +$400K | ﹤0.01% | 2403 |
|
2021
Q1 | $1.66M | Buy |
39,798
+2,402
| +6% | +$100K | ﹤0.01% | 2895 |
|
2020
Q4 | $1.74M | Buy |
37,396
+12,289
| +49% | +$572K | ﹤0.01% | 2753 |
|
2020
Q3 | $1.07M | Buy |
25,107
+165
| +0.7% | +$7.01K | ﹤0.01% | 2890 |
|
2020
Q2 | $1.2M | Sell |
24,942
-1,255
| -5% | -$60.2K | ﹤0.01% | 2818 |
|
2020
Q1 | $1.21M | Sell |
26,197
-5,426
| -17% | -$250K | ﹤0.01% | 2694 |
|
2019
Q4 | $1.9M | Sell |
31,623
-4,496
| -12% | -$270K | ﹤0.01% | 2723 |
|
2019
Q3 | $2.04M | Sell |
36,119
-4,975
| -12% | -$281K | ﹤0.01% | 2620 |
|
2019
Q2 | $2.29M | Buy |
41,094
+7,062
| +21% | +$393K | ﹤0.01% | 2580 |
|
2019
Q1 | $1.72M | Buy |
34,032
+14,925
| +78% | +$753K | ﹤0.01% | 2737 |
|
2018
Q4 | $770K | Buy |
19,107
+4,896
| +34% | +$197K | ﹤0.01% | 3123 |
|
2018
Q3 | $985K | Buy |
14,211
+1,965
| +16% | +$136K | ﹤0.01% | 3105 |
|
2018
Q2 | $927K | Sell |
12,246
-6,479
| -35% | -$490K | ﹤0.01% | 3093 |
|
2018
Q1 | $987K | Sell |
18,725
-1,018
| -5% | -$53.7K | ﹤0.01% | 3026 |
|
2017
Q4 | $1.06M | Buy |
19,743
+3,211
| +19% | +$172K | ﹤0.01% | 2994 |
|
2017
Q3 | $986K | Buy |
16,532
+9,017
| +120% | +$538K | ﹤0.01% | 3051 |
|
2017
Q2 | $593K | Buy |
7,515
+3,679
| +96% | +$290K | ﹤0.01% | 3262 |
|
2017
Q1 | $318K | Sell |
3,836
-12,799
| -77% | -$1.06M | ﹤0.01% | 3403 |
|
2016
Q4 | $1.32M | Buy |
16,635
+12,592
| +311% | +$999K | ﹤0.01% | 2661 |
|
2016
Q3 | $283K | Buy |
+4,043
| New | +$283K | ﹤0.01% | 3441 |
|
2016
Q1 | – | Sell |
-2,337
| Closed | -$207K | – | 4047 |
|
2015
Q4 | $207K | Buy |
+2,337
| New | +$207K | ﹤0.01% | 3722 |
|